| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 405,066 | 421,815 | 436,890 | 424,138 | | Cost of Revenue | 143,294 | 128,062 | 131,669 | 146,463 | | | Gross Profit | 261,772 | 293,753 | 305,221 | 277,675 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,679 | 5,841 | 8,879 | 33,173 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 85,167 | 104,288 | 92,031 | 95,383 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 166,926 | 183,624 | 204,311 | 149,119 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27,897) | (19,411) | (52,673) | (94) | | Earnings Before Interest And Taxes | 161,840 | (131,772) | 147,345 | 143,515 | | Interest Expense | 8,128 | 8,757 | 9,099 | 9,601 | | Income Before Tax | 153,712 | (140,529) | 138,246 | 133,914 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
| (10,344) | (10,611) | (10,142) | | | | Net Income From Continuing Ops | 153,712 | 151,824 | 138,246 | 133,914 | | | Non-recurring Events | | Discontinued Operations | (283) | (134) | (915) | (101) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 153,429 | 151,690 | 137,331 | 133,813 | | Preferred Stock And Other Adjustments | 63,573 | 197,067 | (197,067) |
-
| | | Net Income Applicable To Common Shares | $217,002 | $348,757 | ($59,736) | $133,813 |
|
0.45% Nasdaq 
0.20%
Income Statement
